BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25194449)

  • 1. Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?
    Haro JM; Novick D; Perrin E; Bertsch J; Knapp M
    Psychiatry Res; 2014 Dec; 220(1-2):163-9. PubMed ID: 25194449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
    Jaracz K; Górna K; Kiejda J; Grabowska-Fudala B; Jaracz J; Suwalska A; Rybakowski JK
    Eur Psychiatry; 2015 Nov; 30(8):907-13. PubMed ID: 26647865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.
    Novick D; Haro JM; Suarez D; Lambert M; Lépine JP; Naber D
    Psychopharmacology (Berl); 2007 May; 191(4):1015-22. PubMed ID: 17310386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The European Schizophrenia Outpatient Health Outcomes Study: observational study over 36 months of the French cohort of schizophrenic outpatients treated with antipsychotics].
    Gasquet I; Chartier F; Tcherny-Lessenot S; Lépine JP
    Rev Epidemiol Sante Publique; 2009 Feb; 57(1):25-32. PubMed ID: 19162420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
    Karadayi G; Emiroğlu B; Uçok A
    Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
    Novick D; Haro JM; Suarez D; Vieta E; Naber D
    Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.
    Pinna F; Deriu L; Lepori T; Maccioni R; Milia P; Sarritzu E; Tusconi M; Carpiniello B;
    Psychiatry Res; 2013 Dec; 210(3):739-44. PubMed ID: 24007858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission in the outpatient care of schizophrenia: 3-year results from the Schizophrenia Outpatients Health Outcomes (SOHO) study in France.
    Gasquet I; Haro JM; Tcherny-Lessenot S; Chartier F; Lépine JP
    Eur Psychiatry; 2008 Oct; 23(7):491-6. PubMed ID: 18573640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.
    Brissos S; Dias VV; Balanzá-Martinez V; Carita AI; Figueira ML
    Schizophr Res; 2011 Jul; 129(2-3):133-6. PubMed ID: 21514793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission.
    Yen CF; Cheng CP; Huang CF; Yen JY; Ko CH; Chen CS
    Bipolar Disord; 2008 Jul; 10(5):617-24. PubMed ID: 18657246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Social functioning and quality of life in schizophrenia patients --relationship with symptomatic remission and duration of illness].
    Górna K; Jaracz K; Jaracz J; Kiejda J; Grabowska-Fudala B; Rybakowski J
    Psychiatr Pol; 2014; 48(2):277-88. PubMed ID: 25016765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and employment status in schizophrenia and other psychoses: One-year prospective study in Croatian patients treated with risperidone long acting injection.
    Mihaljevic-Peles A; Sagud M; Filipcic IS; Grosic V; Pedisic I; Emsley R
    Psychiatr Danub; 2016 Sep; 28(3):263-272. PubMed ID: 27658835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.
    Haynes VS; Zhu B; Stauffer VL; Kinon BJ; Stensland MD; Xu L; Ascher-Svanum H
    BMC Psychiatry; 2012 Dec; 12():222. PubMed ID: 23216976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
    J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower subjective quality of life and the development of social anxiety symptoms after the discharge of elderly patients with remitted schizophrenia: a 5-year longitudinal study.
    Kumazaki H; Kobayashi H; Niimura H; Kobayashi Y; Ito S; Nemoto T; Sakuma K; Kashima H; Mizuno M
    Compr Psychiatry; 2012 Oct; 53(7):946-51. PubMed ID: 22554765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.